off-label promotion news from FierceHealthcare
NewsLilly to pay $1.4B to settle Zyprexa marketing charges
For some time now, advocates for seniors have complained that anti-psychotic drugs were being used to chemically restrain demented patients, leaving them sedated and unaware. Now one drugmaker, Eli Read more...
|
